Revanth Reddy Bandaru

Dr. Revanth Reddy Bandaru

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
VGVijay Durga Pradeep Ganipineni
Vijay Durga Pradeep Ganipineni
SJSahas Reddy Jitta
Sahas Reddy Jitta
MGMohan Chandra Vinay Bharadwaj Gudiwada
Mohan Chandra Vinay Bharadwaj Gudiwada
JJJaswanth Jasti
Jaswanth Jasti
CJChaitra Janga
Chaitra Janga
RDRupak Desai
Rupak Desai
Background: Pulmonary hypertension (PH) can lead to cardiac failure, thereby significantly affecting life expectancy and quality of life. Due to inadequate disease surveillance and risk assessment, clinical challenges persist despite advances in diagnosis and treatment. We aimed to review the potential of high-sensitivity cardiac troponin (hs-cTn) as a biomarker for predicting outcomes in PH patients. Methods: A thorough examination of the PubMed and Google Scholar databases was conducted through March 2023. Studies involving adult PH patients and hsTn as a prognostic indicator of outcomes such as mortality, hospitalization, and disease progression were included, after screening their titles and abstracts. Two independent evaluators extracted data, with the quality assessed using the JBI critical appraisal tool. Results: This review uncovered eight studies that examined the prognostic value of hs-cTn in PH patients. Higher hs-cTn levels were associated with increased mortality and hospitalization rates, according to the studies. The severity of PH, cardiac dysfunction, right ventricular function, and systolic dysfunction were associated with hs-cTn. Multiple studies have demonstrated that hsTn has the potential to identify high-risk PH patients who could benefit from targeted therapies and increased clinical monitoring. Conclusions: This review suggests that hsTn may be a biomarker for PH risk stratification and prognosis. Across PH subtypes, elevated hsTn levels predict poor outcomes. However, large-scale prospective studies are needed to confirm hs-cTn’s function in diagnosing pulmonary hypertension and determine its potential value in treatment.

14 February 2024 in Obesity Pillars
Verified
Journal Article
Open access
SNSivaram Neppala
Sivaram Neppala
HCHimaja Dutt Chigurupati
Himaja Dutt Chigurupati
NMNikhilender Nag Mopuru
Nikhilender Nag Mopuru
NANaga Ruthvika Alle
Naga Ruthvika Alle
AJAlpha James
Alpha James
RDRupak Desai
Rupak Desai
Body Mass Index (BMI) has a significant impact on Coronavirus disease (COVID-19) patient outcomes; however, major adverse cardiac and cerebrovascular outcomes in patients with severe sepsis have been poorly understood. Our study aims to explore and provide insight into its association. This is an observational study looking at the impact of BMI on COVID-19-severe sepsis hospitalizations. The primary outcomes are adjusted odds of all-cause in-hospital mortality, respiratory failure, and major adverse cardiac and cerebrovascular events (MACCE), which include acute myocardial infarction, cardiac arrest, and acute ischemic stroke. The secondary outcome was healthcare resource utilization. Coexisting comorbidities and patient features were adjusted with multivariable regression analyses. Of 51,740 patients with severe COVID-19-sepsis admissions, 11.4% were overweight, 24.8% had Class I obesity (BMI 30–34.9), 19.8% had Class II obesity (BMI 35–39.9), and 43.9% had the categorization of Class III obesity (BMI >40) cohorts with age>18 years. The odds of MACCE in patients with class II obesity and class III obesity (OR 1.09 and 1.54; 95CI 0.93–1.29 and 1.33–1.79) were significantly higher than in overweight (p < 0.001). Class I, Class II, and Class III patients with obesity revealed lower odds of respiratory failure compared to overweight (OR 0.89, 0.82, and 0.82; 95CI 0.75–1.05, 0.69–0.97, and 0.70–0.97), but failed to achieve statistical significance (p = 0.079). On multivariable regression analysis, all-cause in-hospital mortality revealed significantly higher odds in patients with Class III obesity, Class II, and Class I (OR 1.56, 1.17, and 1.06; 95CI 1.34–1.81, 0.99–1.38, and 0.91–1.24) vs. overweight patients (p < 0.001). Patients with Class II and Class III obesity had significantly higher odds of MACCE and in-hospital mortality in COVID-19-severe sepsis admissions.

3 March 2023 in JACC
Verified
Journal Article
Closed access
BPBhavin Amrutbhai Patel
Bhavin Amrutbhai Patel
SPSreeram Pannala
Sreeram Pannala
APAyodya R. Perera
Ayodya R. Perera
SHShisheer Havangi
Shisheer Havangi
GPGokul Paidi
Gokul Paidi
RDRupak Desai
Rupak Desai

13 February 2026 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
RDRupak Desai
Rupak Desai
AMAdil Sarvar Mohammed
Adil Sarvar Mohammed
HAHafeezuddin Ahmed
Hafeezuddin Ahmed
KAKokou Selom Adompreh-Fia
Kokou Selom Adompreh-Fia
NGNarendranath Reddy Ganampet
Narendranath Reddy Ganampet
RARakesh Allamneni
Rakesh Allamneni

18 May 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
AMAvilash Mondal
Avilash Mondal
ABAditi Kishor Bhanushali
Aditi Kishor Bhanushali
RBRevanth Reddy Bandaru
Revanth Reddy Bandaru
ASAanchal Sawhney
Aanchal Sawhney
PNPratiksha Shankarlal Nathani
Pratiksha Shankarlal Nathani
RDRupak Desai
Rupak Desai